Chamberlain et al. examined the relationship between CRP and clinical features of major depressive disorder (MDD) by comparing treatment-resistant (n = 102), treatment-responsive (n = 48), untreated patients (n = 48), and healthy controls (n = 54). The gene discussed is CRP; the disease is major depressive disorder.